Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 20 Conferences, 16 Workshop and 7 relevant Journals are presently dedicated exclusively to medicines during pregnancy and about 361 articles are being published on Medicines during Pregnancy.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Maternal-fetal medicine (MFM) is the branch of obstetrics that focuses on the medical and surgical management of high-risk pregnancies. Management includes monitoring and treatment including comprehensive ultrasound, chorionic villus sampling, genetic amniocentesis, and fetal surgery or treatment. Obstetricians who practice maternal-fetal medicine are also known as perinatologists. This is a subspecialty to obstetrics and gynecology mainly used for patients with high-risk pregnancies.
It is not unusual for pregnant women to feel under the weather. Also, little is known about the effects of taking most medications during pregnancy. For minor condition, There are plenty of over-the-counter drugs but all of them are not safe to consume during the pregnancy. Although most of the over-the-counter drugs have an excellent safety figure, some are known to affect the foetus adversely. As the foetus is going through critical stages of development, these drugs can affect him/her in a very different manner than they affect the mother, at times leading to birth defects or other physical or mental problems.
Safe consumption of drugs is essential to optimize the health of both the baby and the pregnant woman. Not using and medication that one needs can be more harmful to the mother and the baby than using the medicine. Plenty of pregnant women take prescription medications for health conditions like asthma, diabetes, seizures, and heartburn. The safety of some drugs might change with the gestational age of the fetus. Around 1 percent or more of birth defects result from maternal drug exposure, as a result of which the U.S. Food and Drug Administration has assigned risk categories to each drug. Plenty of drugs are not evaluated in the controlled trials and probably will never be dut to ethical reasons. The most commonly consumed OTC pain drugs are acetaminophen (Tylenol), aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), including ketoprofen (Orudis), ibuprofen (Advil, Motrin)and naproxen (Aleve).When you are pregnant, it is necessary to ask the doctor about the medication that are safe and the ones you need to find alternatives for. Medications labelled 'herbal' or 'natural' may also have unknown side effects on the baby.
Most herbal preparations and supplements have not been proven to be safe during pregnancy. When it comes to prenantals, they are essential as well as safe during pregnancy. A few alternative therapies like acupuncture have proved to be safe and effective for pregnant women to relieve some of the uncomfortable side effects of pregnancy. But one must always talk it over with their doctor before using any of them. Clinical trials conducted after releasing the drugs in the market have proved that certain medications during pregnancy cause serious birth defects. While some medications are known to be harmful when taken during pregnancy, the safety or risks of most medications are unknown. The effects depend on many factors, such as the dosage/route of administration; the trimester medication is taken, other health conditions of the pregnant woman, other medications taken by the pregnant woman etc.
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants and investigates pipeline products and technologies.
The total market for reproductive technologies and products is estimated to achieve revenues of nearly $16.1 billion in 2013. In 2018, the forecasted revenues will likely reach $19.6 billion, demonstrating a compound annual growth rate (CAGR) of 4.1%.
Relevant Society and Associations:
This page will be updated regularly.
This page was last updated on March 4, 2021